2-Substituted-16-ene-22-thia-1α, 25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs:: Synthesis, biological evaluation, and crystal structure

被引:46
|
作者
Shimizu, Masato [1 ]
Miyamoto, Yukiko [1 ]
Takaku, Hajime [1 ]
Matsuo, Mayumi [1 ,2 ]
Nakabayashi, Makoto [1 ]
Masuno, Hiroyuki
Udagawa, Nobuyuki [3 ]
DeLuca, Hector F. [4 ]
Ikura, Teikichi [5 ]
Ito, Nobutoshi [5 ]
机构
[1] Tokyo Med & Dent Univ, Sch Biomed Sci, Med Chem Lab, Chiyoda Ku, Tokyo 1010062, Japan
[2] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan
[3] Matsumoto Dent Univ, Dept Biochem, Nagano 3990781, Japan
[4] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA
[5] Tokyo Med & Dent Univ, Sch Biomed Sci, Struct Biol Lab, Bunkyo Ku, Tokyo 1138510, Japan
关键词
16-ene-22-thia-19-norvitamin D; VDR-binding affinity; transcriptional activity; structure-activity relationships; crystal structure;
D O I
10.1016/j.bmc.2008.05.043
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recently, we have found that 16-ene-22-thia-26,27-dimethyl-19-norvitamin D(3) analogs 1a (n = 2, 3) are 20 times more active than the natural hormone 1a, 25-dihydroxyvitamin D3 in terms of transcriptional activity. To further investigate the effects of the A-ring modi. cation of 1a, b on the biological activity pro. le, novel 22-thia-19-norvitamin D analogs 2-11 bearing a hydroxyethoxy-, hydroxyethylidene- or methyl group at C-2 in combination with 20S- and 20R-isomers were prepared and tested for their in vitro biological activities. All of the synthesized analogs showed 0.5-140% of the activity of the natural hormone in binding to the vitamin D receptor (VDR). When compared with the transcriptional activity of C-2 or C- 20 isomeric pairs of the 22-thia analogs, the 20S- isomers 2-11a were more potent than the 20R- isomers 2, 3, 8-11b, and the 2 beta-hydroxyethoxy, 2E-hydroxyethylidene, and 2 alpha-methyl-2 beta-hydroxy-22-thia isomers showed higher potency than their corresponding counterparts. In particular, 3a exhibited an extremely higher level of potency (210-fold) than the natural hormone. To elucidate the action mode of superagonist 3a at the molecular level, we determined the crystal structures of the rat VDR-ligand-binding domain complexed with 3a or 3b in the presence of peptide containing a nuclear box motif (LxxLL) at 1.9-2.0 angstrom resolution. The crystal structures demonstrated that the 1 alpha-OH, 3 beta-OH, and 25-OH groups of the natural hormone and 3a were anchored by the same amino acid residues in the ligand-binding pocket, and the terminal OH moiety of the substituent at C-2 formed hydrogen bonds with Arg270 and a water molecule to create a tight water molecule network. Moreover, the methyl groups at C-26a and C-27a make additional contact with hydrophobic residues such as Leu223, Ala227, Val230, and Ala299. These hydrophilic and hydrophobic interactions in 3a may underlie the induction of superagonistic activity. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6949 / 6964
页数:16
相关论文
共 44 条
  • [1] Synthesis and structure-activity relationships of 16-ene-22-thia-1α,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs having side chains of different sizes
    Takaku, Hajime
    Miyamoto, Yukiko
    Asami, Shiori
    Shimazaki, Mika
    Yamada, Sachiko
    Yamamoto, Keiko
    Udagawa, Nobuyuki
    DeLuca, Hector F.
    Shimizu, Masato
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (04) : 1796 - 1815
  • [2] Synthesis and biological evaluation of novel 6-substituted analogs of 1α,25-dihydroxy-19-norvitamin D3
    Sokolowska, Katarzyna
    Sicinski, Rafal R.
    Mourino, Antonio
    Plum, Lori A.
    DeLuca, Hector F.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2013, 136 : 30 - 33
  • [3] SYNTHESIS AND PRELIMINARY BIOLOGICAL EVALUATION OF 2-[3-(TETRAZOLYL)PROPYL]-1α,25-DIHYDROXY-19-NORVITAMIN D3
    Takano, Masashi
    Higuchi, Erika
    Higashi, Kazunari
    Hirano, Keisuke
    Takeuchi, Akiko
    Sawada, Daisuke
    Kittaka, Atsushi
    HETEROCYCLES, 2015, 90 (02) : 1274 - 1287
  • [4] Design, synthesis, and biological evaluation of a 1α,25-dihydroxy-19-norvitamin D3 analogue with a frozen a-ring conformation
    Sicinski, Rafal R.
    Glebocka, Agnieszka
    Plum, Lori A.
    DeLuca, Hector F.
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (24) : 6154 - 6164
  • [5] 13-Methyl-substituted des-C, D analogs of (20S)-1α,25-dihydroxy-2-methylene-19-norvitamin D3 (2MD): Synthesis and biological evaluation
    Plonska-Ocypa, Katarzyna
    Sicinski, Rafal R.
    Plum, Lori A.
    Grzywacz, Pawel
    Frelek, Jadwiga
    Clagett-Dame, Margaret
    DeLuca, Hector F.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (04) : 1747 - 1763
  • [6] Synthesis and biological activities of new 1α,25-dihydroxy-19-norvitamin D3 analogs with modifications in both the A-ring and the side chain
    Shimizu, Masato
    Miyamoto, Yukiko
    Kobayashi, Emi
    Shimazaki, Mika
    Yamamoto, Keiko
    Reischl, Wolfgang
    Yamada, Sachiko
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (12) : 4277 - 4294
  • [7] Synthesis, metabolism, and biological activity of 2-[3-(tetrazolyl)propyl]-1α,25-dihydroxy-19-norvitamin D3
    Takano, Masashi
    Yasuda, Kaori
    Higuchi, Erika
    Tohyama, Eri
    Takeuchi, Akiko
    Sakaki, Toshiyuki
    Kittaka, Atsushi
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2016, 164 : 40 - 44
  • [8] THE SYNTHESIS AND BIOLOGICAL-ACTIVITY OF 25-HYDROXY-26,27-DIMETHYLVITAMIN-D3 AND 1,25-DIHYDROXY-26,27-DIMETHYLVITAMIN-D3 - HIGHLY POTENT NOVEL ANALOGS OF VITAMIN-D3
    GILL, HS
    LONDOWSKI, JM
    CORRADINO, RA
    ZINSMEISTER, AR
    KUMAR, R
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1988, 31 (02): : 147 - 160
  • [9] Analogs of 1α,25-dihydroxyvitamin D3 with high potency in induction of osteoclastogenesis and prevention of dendritic cell differentiation:: Synthesis and biological evaluation of 2-substituted 19-norvitamin D analogs
    Shimazaki, Mika
    Miyamoto, Yukiko
    Yamamoto, Keiko
    Yamada, Sachiko
    Takami, Masamichi
    Shinki, Toshimasa
    Udagawa, Nobuyuki
    Shimizu, Masato
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (13) : 4645 - 4656